A truly universal flu vaccine continues to evade scientists, but it should be possible to develop a vaccine that offers broader strain protection – and lasts longer. Eric Weaver, assistant professor at the University of Nebraska, certainly believes we can do better when it comes to influenza vaccines; his team have developed a vaccine that carries the centralized genes for H1, H2, H3, and H5, with the aim of providing immunity against all evolved strains (1). We speak with Weaver to learn more.

References
- A Lingel et al., “Efficacy of an adenoviral vectored multivalent centralized influenza vaccine”, Sci Rep, 7, 14912 (2017). PMID: 29097763.